Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Palonosetron vs Combination of Granisetron and Dexamethasone in Preventing PONV in Laparoscopic Cholecystectomy. [Phase 4]
A Phase 4 clinical trial comparing palonosetron to a combination of granisetron and dexamethasone for prevention of postoperative nausea and…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy [Phase 2]
Phase 2 clinical trial update assessing a prophylaxis strategy for postoperative nausea and vomiting after laparoscopic cholecystectomy.
-
FDA approval · 2023-08-25FDA Approved: PALONOSETRON — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Palonosetron hydrochloride from Apotex Corp., confirming its generic use. Palonosetron is used t…
-
FDA approval · 2023-08-14FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' palonosetron hydrochloride generic under an Original Application for preventing postoperative nausea …
-
FDA approval · 2023-05-24FDA Approved: ONDANSETRON — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Ondansetron, manufactured by Accord Healthcare, Inc., signaling an update to its regulatory stat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-05-01FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited, approving this generic an…
-
FDA approval · 2023-05-01FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride submitted by Onesource Specialty Pharma Limited (ANDA 078257). This ac…
-
FDA approval · 2023-04-26FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for ondansetron submitted by West-Ward Pharmaceuticals Corp, indicating an approved change to an exi…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV. [Phase 3]
Phase 3 clinical trial comparing amisulpride to placebo for prevention of postoperative nausea and vomiting (PONV) in high-risk patients; st…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery [Phase 2]
Phase 2 trial evaluating TAK-951 for prevention of postoperative nausea and vomiting (PONV) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy [Phase 4]
A Phase 4 trial evaluating botulinum toxin pyloroplasty to reduce postoperative nausea and vomiting after sleeve gastrectomy has completed.
-
FDA approval · 2023-04-04FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (Bionpharma Inc.)
FDA approved an Original Application for Prochlorperazine Maleate from Bionpharma Inc., authorizing its marketing as a generic antiemetic.
-
FDA approval · 2023-03-17FDA Approved: PROCHLORPERAZINE MALEATE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved Prochlorperazine maleate from Glenmark Pharmaceuticals under an Original Application; it is an antiemetic indicated to prevent …
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting [Phase 4]
Phase 4 clinical trial investigating whether aprepitant reduces postoperative nausea and vomiting.
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Olanzapine for the Prevention of Postoperative Nausea and Vomiting [Phase 1, Phase 2]
Phase 1/2 trial updates the investigation of olanzapine for preventing postoperative nausea and vomiting; study status is completed.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron [Phase 4]
Phase 4 trial comparing postoperative anti-nausea and vomiting effects of glycopyrronium vs. ondansetron.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Effect of Propofol on Postoperative Nausea and Vomiting. [Phase 4]
Phase 4 clinical trial evaluating the effect of propofol on postoperative nausea and vomiting has been completed.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Triple Therapy for Postoperative Nausea and Vomiting in Laparoscopic Gastrointestinal Surgery [Phase 3]
Phase 3 clinical trial evaluating triple therapy for postoperative nausea and vomiting in laparoscopic gastrointestinal surgery has complete…
-
CLINICAL_TRIALS withdrawal · 2022-12-12Clinical Trial Update: Intranasal Lidocaine for Prevention of Postoperative Nausea and Vomiting. [Phase 4]
A Phase 4 trial of intranasal lidocaine for preventing postoperative nausea and vomiting has been withdrawn.
-
FDA approval · 2022-12-06FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
FDA approved Cumberland Pharmaceuticals' Supplemental Application for SANCUSO (granisetron), marking an updated approval for this antiemetic…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery [Phase 4]
Phase 4 trial update investigating postoperative nausea and vomiting in laparoscopic abdominal surgery.
-
FDA approval · 2022-11-09FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ondansetron hydrochloride from Sun Pharmaceutical Industries, Inc., under an ANDA. This docu…
-
FDA approval · 2022-11-09FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' supplemental application for ondansetron, an antiemetic. The approval indicates a change to the …
-
FDA approval · 2022-11-02FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic promethazine hydrochloride under an original ANDA. The approval authorizes marketing of the gen…
-
FDA label_change · 2022-09-14FDA Approved: BARHEMSYS — Supplemental Application (Acacia Pharma Ltd)
FDA approved a supplemental application for BARHEMSYS (amisulpride) submitted by Acacia Pharma Ltd, typically reflecting labeling changes.